Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.36
-0.51 (-4.69%)
At close: Nov 13, 2026, 4:00 PM EST
9.62
-0.74 (-7.16%)
After-hours: Nov 13, 2026, 7:30 PM EST
Climb Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 39.73 | 35.69 | 87.23 | 93.11 | 43.59 | 46.92 |
Short-Term Investments | 165.69 | 65.4 | 63.69 | 13.69 | 79.98 | 89.56 |
Cash & Short-Term Investments | 205.42 | 101.08 | 150.92 | 106.8 | 123.57 | 136.48 |
Cash Growth | 136.39% | -33.02% | 41.31% | -13.57% | -9.46% | 566.18% |
Other Receivables | - | - | - | 2.46 | 6.59 | 7.02 |
Receivables | - | - | - | 2.46 | 6.59 | 7.02 |
Prepaid Expenses | 4.73 | 4.77 | 3.95 | 0.85 | 3.88 | 4.4 |
Other Current Assets | - | - | - | 0.15 | 0.36 | 0.35 |
Total Current Assets | 210.15 | 105.85 | 154.87 | 110.26 | 134.39 | 148.25 |
Property, Plant & Equipment | 2.32 | 0.79 | 0.69 | 0.2 | 0.47 | - |
Long-Term Investments | 22.2 | 59.57 | 61.61 | - | - | 24.92 |
Other Long-Term Assets | 1.89 | 1.53 | 0.02 | 0.02 | 0.13 | 0.07 |
Total Assets | 236.56 | 167.74 | 217.19 | 110.47 | 134.99 | 173.24 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.06 | 2.27 | 0.71 | 0.07 | 0.75 | 1.4 |
Accrued Expenses | 6.39 | 4.46 | 4.07 | 1.23 | 5.05 | 4.63 |
Current Portion of Leases | 0.46 | 0.26 | 0.16 | 0.33 | 0.3 | - |
Other Current Liabilities | - | - | - | 1.2 | - | - |
Total Current Liabilities | 7.91 | 6.98 | 4.93 | 2.83 | 6.1 | 6.03 |
Long-Term Leases | 0.61 | 0.29 | 0.38 | 0.02 | 0.18 | - |
Other Long-Term Liabilities | - | - | - | 0.02 | - | 0.01 |
Total Liabilities | 8.51 | 7.27 | 5.31 | 2.87 | 6.28 | 6.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 |
Additional Paid-In Capital | 560.1 | 449.76 | 441.73 | 263.58 | 249.93 | 242.94 |
Retained Earnings | -331.52 | -289.73 | -229.88 | -155.98 | -120.86 | -75.62 |
Comprehensive Income & Other | -0.53 | 0.44 | 0.02 | -0 | -0.36 | -0.12 |
Total Common Equity | 228.05 | 160.48 | 211.88 | 107.6 | 128.72 | 167.2 |
Shareholders' Equity | 228.05 | 160.48 | 211.88 | 107.6 | 128.72 | 167.2 |
Total Liabilities & Equity | 236.56 | 167.74 | 217.19 | 110.47 | 134.99 | 173.24 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.07 | 0.54 | 0.53 | 0.35 | 0.48 | - |
Net Cash (Debt) | 226.56 | 160.11 | 212 | 106.45 | 123.09 | 161.4 |
Net Cash Growth | 29.28% | -24.47% | 99.15% | -13.52% | -23.74% | 687.81% |
Net Cash Per Share | 3.14 | 2.36 | 4.40 | 3.94 | 4.68 | 13.16 |
Filing Date Shares Outstanding | 58.74 | 47.77 | 67.48 | 27.72 | 26.57 | 26.57 |
Total Common Shares Outstanding | 57.73 | 47.77 | 67.26 | 27.7 | 26.57 | 26.24 |
Working Capital | 202.24 | 98.87 | 149.94 | 107.42 | 128.3 | 142.22 |
Book Value Per Share | 3.95 | 3.36 | 3.15 | 3.88 | 4.84 | 6.37 |
Tangible Book Value | 228.05 | 160.48 | 211.88 | 107.6 | 128.72 | 167.2 |
Tangible Book Value Per Share | 3.95 | 3.36 | 3.15 | 3.88 | 4.84 | 6.37 |